Memoli, Matthew
- National Institute of Allergy and Infectious Diseases (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #429
- Sustained Excellence
- Top 5% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$7.1M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#429
By linked amount among FY2023 PIs
Earliest Year Loaded
2017
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Memoli, Matthew as a PI. Multi-PI records show the full award amount for context.
- 1ZIAAI001157-12ZIAContact PIPandemic Influenza Translational Research and novel universal countermeasure development$5.3Maward amount
- 1ZIAAI001221-07ZIAContact PIClinical and translational evaluation of vaccination strategies for Zika, Chikungunya, Dengue, Leishmania, Malaria, and other important or emerging vector-borne diseases$1Maward amount
- 1ZIAAI001268-04ZIAContact PICoronavirus Pathogenesis and Broadly Protective Vaccine Development$718.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Memoli, Matthew as a PI.
FY2023 award administered by National Institute of Allergy and Infectious Diseases ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardNational Institute of Allergy and Infectious Diseases
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017$2M Cumulative Funding
- 2017$5M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #266
- 2017Entered Top 25% NationallyRanked #266
- 2017Entered Top 10% NationallyRanked #266
- 2017Entered Top 5% NationallyRanked #266
- 2018$10M Cumulative Funding
- 2023$25M Cumulative Funding